National Hospital Organization Sagamihara National Hospital

Sagamihara 252-0392

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Eczema, Receptors, Fibroblast Growth Factor, Rheumatoid Arthritis, Urothelial Cancer

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed